8 reports

Genetic Biomarkers ##. ##. ##.

  • Cancer Biomarker
  • Genomics
  • United States
  • Forecast
  • Market Size
  • European Cancer Biomarkers Market - By Type - Genetic Biomarkers
  • Cancer Biomarkers Market: Revenue in USD million, by Region, by Type, by Genetic Biomarker

Cancer Biomarkers Market The market for Global Cancer Biomarkers is highly dynamic. The Cancer Biomarkers market is expected to reach USD XXmillion by 2022 from USD XXmillion in 2016, at a CAGR of XX%. Biomarkers are chemical, physical or biological parameters which can be used to indicate disease states. Oncology biomarkers offers...

  • Cancer Biomarker
  • North America
  • United States
  • World
  • Market Size

GLOBAL CANCER BIOMARKER MARKET FORECAST 2017-2025 ##.

  • Cancer Biomarker
  • Genomics
  • World
  • Market Size

LIST OF TABLES ##.

  • Cancer Biomarker
  • Genomics
  • World
  • Market Size

Global Cancer Biomarkers Market Research and Analysis 2015-2022 ##.

  • Cancer Biomarker
  • Genomics
  • APAC
  • World

The magnitude of the impact has been categorized as described below: Low Moderate - Medium-level impact on the market High - Negligible or no impact on the market landscape - Very high impact, with radical influence on the growth of the market ## ## ## ## ## ## ## ## ## ## Low High

  • Cancer Biomarker
  • Abbott Laboratories, Inc.
  • Affymetrix, Inc.
  • Illumina, Inc.
  • QIAGEN N.V.
  • EUROPE: GENETIC CANCER BIOMARKERS MARKET, BY COUNTRY, 2015-2022 (USD MILLION)
  • GLOBAL GENETIC CANCER BIOMARKERS MARKET, BY REGION, 2015-2022 (USD MILLION)

Global cancer biomarkers market projected to grow at CAGR of 12.2% The global cancer biomarkers market is projected to reach USD 20.48 billion by 2022 from USD 11.53 billion in 2017, at a CAGR of 12.2% from 2017 to 2022. Over the years, the cancer biomarkers market has evolved significantly owing to...

  • Cancer
  • Cancer Biomarker
  • North America
  • United States
  • Market Size
  • GLOBAL CANCER BIOMARKER MARKET, FOR GENETIC BIOMARKER 2014-2023 (USD MILLION)
  • OF NOVEL DRUGS TARGETING GENETIC BIOMARKERS IS ESTIMATED TO BOOST GROWTH OF THIS SEGMENT.

Introduction Most healthcare professionals use diagnostic tests to clarify and support their clinical decision making. Cancer biomarkers are substances or processes that indicate the presence of cancers in the human body. Biomarkers may be produced naturally by the affected tissue or by immune cells in the body in response...

  • Cancer Biomarker
  • North America
  • United States
  • World
  • Market Size